Drugs / ARUNDIC ACID
ARUNDIC ACID
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 24 trials | ||||||
| Phase 2 | NCT00694941 | Jun → Dec 2008 | amyotrophic lateral sclerosis | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT00401310 | Jul 2007 → Jan 2009 | middle cerebral artery infarction | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
| Phase 2 | NCT00083421 | Jun 2004 → Jul 2007 | Alzheimer disease | Ono Pharma USA Inc | Completed | No outcome recorded |
| Phase 2 | NCT00212693 | Jan 2004 → Sep 2005 | Parkinson disease | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT00229177 | Sep 2005 → Sep 2008 | stroke disorder | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2/3 | NCT00046761 | Nov 2002 → May 2005 | stroke disorder | Ono Pharma USA Inc | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00403104 Comparator | Nov 2006 → Dec 2008 | amyotrophic lateral sclerosis | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARUNDIC ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL3187683 ↗ |
| Known as | Acide arundique | ChEMBL registry synonym — accepted as the source's own label CHEMBL3187683 ↗ |
| Known as | Acido arundico | ChEMBL registry synonym — accepted as the source's own label CHEMBL3187683 ↗ |
| Known as | MK0724 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00401310 ↗ |
| Known as | ONO-2506 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00046761 ↗ |
| Known as | ONO-2506PO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00694941 ↗ |
| Modality | Small molecule | — CHEMBL3187683 ↗ |
| Route | Intravenous | “ONO-2506 Intravenous Infusion” NCT00046761 ↗ |